These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34783181)

  • 1. Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis.
    Liu J; Wang J; Yan X; Xue R; Zhan J; Jiang S; Geng Y; Liu Y; Mao M; Xia J; Yin S; Tong X; Chen Y; Ding W; Huang R; Wu C
    Hepatol Commun; 2022 Apr; 6(4):855-866. PubMed ID: 34783181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological features of chronic hepatitis B patients with normal alanine aminotransferase according to different criteria.
    Huang R; Liu J; Wang J; Qiu Y; Zhu L; Li Y; Liu Y; Zhan J; Xue R; Jiang S; Geng Y; Wan Y; Li M; Mao M; Gao D; Gu Y; Zhang Y; Yin S; Tong X; Xia J; Yan X; Ding W; Chen Y; Li J; Zhu C; Wu C
    Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38206209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic characteristics of liver inflammation and fibrosis in 310 patients with chronic hepatitis B.
    Jiang C; Liu J; Li R; Chen K; Peng W; Fu L; Peng S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):698-706. PubMed ID: 37539572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis.
    Sonneveld MJ; Brouwer WP; Hansen BE; Chan HL; Piratvisuth T; Jia JD; Zeuzem S; Chien RN; Choi H; de Knegt RJ; Wat C; Pavlovic V; Gaggar A; Xie Q; Buti M; de Man RA; Janssen HLA;
    Aliment Pharmacol Ther; 2020 Oct; 52(8):1399-1406. PubMed ID: 32886813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALT Levels in Treatment-Naive, Chronic Hepatitis B Patients with Concurrent Fatty Liver Disease: A US Nationwide Study.
    Chang CY; Kam L; Dang N; Cheung R; Nguyen MH
    Dig Dis; 2022; 40(4):497-505. PubMed ID: 34348281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.
    Park JY; Park YN; Kim DY; Paik YH; Lee KS; Moon BS; Han KH; Chon CY; Ahn SH
    J Viral Hepat; 2008 Aug; 15(8):615-21. PubMed ID: 18573162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
    Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J
    J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.
    Alam S; Ahmad N; Mustafa G; Shrestha A; Alam AK; Khan M
    Liver Int; 2011 Jul; 31(6):824-30. PubMed ID: 21645213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B.
    Duan M; Chi X; Xiao H; Liu X; Zhuang H
    Hepatol Int; 2021 Apr; 15(2):318-327. PubMed ID: 33638049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. East Asia expert opinion on treatment initiation for chronic hepatitis B.
    Kao JH; Hu TH; Jia J; Kurosaki M; Lim YS; Lin HC; Sinn DH; Tanaka Y; Wai-Sun Wong V; Yuen MF
    Aliment Pharmacol Ther; 2020 Nov; 52(10):1540-1550. PubMed ID: 32951256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatic pathological characteristics and factors influencing alanine transaminase value below twice the upper limit of normal in patients with chronic hepatitis B].
    Wang XH; Liu XQ; Cai DC; Hu P; Li H
    Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):483-488. PubMed ID: 37365024
    [No Abstract]   [Full Text] [Related]  

  • 15. Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levels.
    Hu KQ; Schiff ER; Kowdley KV; Min AD; Shiffman ML; Lee WM; Goodman ZD; Dau LO; Peschell KJ; Fagan EA; Flaherty JF
    J Clin Gastroenterol; 2010 Aug; 44(7):510-6. PubMed ID: 20179614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of individuals with chronic hepatitis B virus infection and persistent normal or mildly elevated aminotransferase levels.
    Yan JY; Li ZQ; Yu ZJ; Kan QC
    J Cell Biochem; 2019 Apr; 120(4):6632-6641. PubMed ID: 30368885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤ 40 IU/L and significant hepatic fibrosis.
    Chao DT; Lim JK; Ayoub WS; Nguyen LH; Nguyen MH
    Aliment Pharmacol Ther; 2014 Feb; 39(4):349-58. PubMed ID: 24387289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the predictive value of plateletcrit for the degree of liver fibrosis in patients with chronic HBV infection with ALT less than two times the upper limit of normal].
    Wang B; Li Y; Xiao L; Xu HT; Xian JC
    Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):862-868. PubMed ID: 37723069
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase.
    Wang D; Zhang P; Zhang M
    Exp Ther Med; 2017 Dec; 14(6):5363-5370. PubMed ID: 29285064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.
    Praneenararat S; Chamroonkul N; Sripongpun P; Kanngurn S; Jarumanokul R; Piratvisuth T
    BMC Gastroenterol; 2014 Dec; 14():218. PubMed ID: 25523185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.